Celltrion Investor
Celltrion engaged in the research, development, and manufacture of therapeutic proteins.
Investor Type:
Private Equity Funds
Technology:
AI-driven Drug Target Identification
Founded Date:
2002-02-01
Industry:
BioPharma AI
Employee Number:
501-1000
Funding Status:
public
Headquarters:
Incheon,Inch'on-jikhalsi,South Korea,Asia